Sponsors

Lead Sponsor

University Hospital of Ferrara

22 PD patients were randomized into LCIG monotherapy (n-OPC 11 patients) and LCIG+OPC (add-OPC 11 patients), further divided according to OPC adding time (E-OPC within one month and L-OPC after one month from LCIG implant). Data on PD clinical aspects, Montreal Cognitive Assessment (MoCA), Unified Parkinson's Disease Rating Scale (UPDRS), Unified Dyskinesia Rating Scale (UDysRS), electroneurography (ENG), and pharmacological therapy (Levodopa Equivalent Dose-LEDD) were collected before LCIG implanted (T0) and in the following 12 (T1) months.

Related studies

RECRUITING

Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms

Effect of Motor Imagery Added to Rehabilitation on Balance and Kinesiophobia in Patients With Parkinson's Disease

Trial snapshot

Condition

Locations shown

For caregivers